Systemic inflammation at the time of experimental stroke has been used experimentally to mimic the clinical situation of infection to increase the likelihood of developing a detrimental autoimmune response to brain antigens (Becker et al., 2011) by favoring Th1 responses to MBP (Becker et al., 2005; Zierath et al., 2010). Here, MBP is linked to stroke disorder.